{"id":10985,"date":"2025-11-20T14:09:45","date_gmt":"2025-11-20T20:09:45","guid":{"rendered":"https:\/\/ibio.org\/?p=10985"},"modified":"2025-11-20T14:09:45","modified_gmt":"2025-11-20T20:09:45","slug":"abbotts-21b-exact-sciences-buy-marks-a-big-bet-on-cancer-screening","status":"publish","type":"post","link":"https:\/\/ibio.org\/abbotts-21b-exact-sciences-buy-marks-a-big-bet-on-cancer-screening\/","title":{"rendered":"Abbott\u2019s $21B Exact Sciences Buy Marks a Big Bet on Cancer Screening"},"content":{"rendered":"<p data-start=\"174\" data-end=\"436\">Abbott confirmed a <strong data-start=\"193\" data-end=\"208\">$21 billion<\/strong> deal to acquire Exact Sciences, instantly becoming one of the biggest moves in diagnostics in years. Abbott will pay <strong data-start=\"326\" data-end=\"352\">$105 per share in cash<\/strong>, a <strong data-start=\"356\" data-end=\"371\">51% premium<\/strong>, sending Exact\u2019s stock sharply higher for a second straight day.<\/p>\n<p data-start=\"438\" data-end=\"807\">The deal gives Abbott a dominant foothold in <strong data-start=\"483\" data-end=\"503\">cancer screening<\/strong>, powered by Exact\u2019s flagship <strong data-start=\"533\" data-end=\"546\">Cologuard<\/strong> test and a crowded pipeline of next-generation screening tools, including Cologuard Plus and several liquid-biopsy programs. CEO Robert Ford emphasized growth over cost-cutting, though analysts see room for efficiencies in sales infrastructure and procurement.<\/p>\n<p data-start=\"809\" data-end=\"1223\">Exact\u2019s footprint \u2014 6,500 employees, nine R&amp;D centers, and more than <strong data-start=\"878\" data-end=\"924\">20 million Cologuard tests used since 2014<\/strong> \u2014 positions Abbott to scale quickly across primary care, where both companies already have deep commercial reach. But the combo isn\u2019t plug-and-play: the two companies have different operating models, and Ford downplayed expectations of broad cross-selling between Cologuard and products like Libre.<\/p>\n<p data-start=\"1225\" data-end=\"1572\">The acquisition continues a surge in health-care M&amp;A and could spark a new wave of consolidation across diagnostics. With the deal slated to close in <strong data-start=\"1375\" data-end=\"1387\">mid-2026<\/strong>, investors will be watching how Abbott integrates Exact\u2019s sprawling cancer-screening pipeline \u2014 and whether the company can convert this massive swing into long-term market leadership.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Abbott confirmed a $21 billion deal to acquire Exact Sciences, instantly becoming one of the biggest moves in diagnostics in years. Abbott will pay $105 per share in cash, a 51% premium, sending Exact\u2019s stock sharply higher for a second straight day. The deal gives Abbott a dominant foothold in cancer screening, powered by Exact\u2019s [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[145],"tags":[237,262,697,696,121,125,235],"class_list":["post-10985","post","type-post","status-publish","format-standard","hentry","category-community-news","tag-abbott","tag-chicago","tag-cologuard","tag-exact-sciences","tag-illinois","tag-medical-device","tag-medtech"],"_links":{"self":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10985","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/comments?post=10985"}],"version-history":[{"count":1,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10985\/revisions"}],"predecessor-version":[{"id":10986,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/posts\/10985\/revisions\/10986"}],"wp:attachment":[{"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/media?parent=10985"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/categories?post=10985"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ibio.org\/wp-json\/wp\/v2\/tags?post=10985"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}